Abstract
Although agonists and competitive antagonists presumably occupy overlapping binding sites on ligand-gated channels, these interactions cannot be identical because agonists cause channel opening whereas antagonists do not. One explanation is that only agonist binding performs enough work on the receptor to cause the conformational changes that lead to gating. This idea is supported by agonist binding rates at GABAA and nicotinic acetylcholine receptors that are slower than expected for a diffusion-limited process, suggesting that agonist binding involves an energy-requiring event. This hypothesis predicts that competitive antagonist binding should require less activation energy than agonist binding. To test this idea, we developed a novel deconvolution-based method to compare binding and unbinding kinetics of GABAA receptor agonists and antagonists in outside-out patches from rat hippocampal neurons. Agonist and antagonist unbinding rates were steeply correlated with affinity. Unlike the agonists, three of the four antagonists tested had binding rates that were fast, independent of affinity, and could be accounted for by diffusion- and dehydration-limited processes. In contrast, agonist binding involved additional energy-requiring steps, consistent with the idea that channel gating is initiated by agonist-triggered movements within the ligand binding site. Antagonist binding does not appear to produce such movements, and may in fact prevent them.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 2660-2670 |
| Number of pages | 11 |
| Journal | Biophysical Journal |
| Volume | 81 |
| Issue number | 5 |
| DOIs | |
| State | Published - 2001 |
Funding
M.V.J. was sponsored in part by the American Epilepsy Society with support from the Milken Family Medical Foundation. Y.S. was supported by a Core Research for Evolutional Science and Technology program from the Japanese Science and Technology Corporation. This work was supported by National Institutes of Health grant NS26494 (G.L.W.), Deutsche Forschungsgemeinschaft grant Jo-248/2–1 (P.J.), and a grant from the Human Frontiers Research Program Organization.
| Funders | Funder number |
|---|---|
| Human Frontiers Research Program Organization | |
| Japanese Science and Technology Corporation | |
| Author National Institutes of Health National Institutes of Health National Institutes of Health National Institutes of Health The Bev Hartig Huntington's Disease Foundation National Institutes of Health | |
| National Institute of Neurological Disorders and Stroke | R01NS026494 |
| Milken Family Foundation | |
| American Epilepsy Society/Epilepsy Foundation of America | |
| Deutsche Forschungsgemeinschaft | Jo-248/2–1 |
| Core Research for Evolutional Science and Technology |
ASJC Scopus subject areas
- Biophysics
Fingerprint
Dive into the research topics of 'Microscopic kinetics and energetics distinguish GABAA receptor agonists from antagonists'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS